Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Ansa Biotechnologies

Ansa Biotechnologies

Ansa Biotechnologies is building a faster and cheaper DNA synthesis service to accelerate synthetic biology research. Ansa's core technology is a novel DNA synthesis method based on enzymes that will be faster, cleaner and more accurate than existing methods. The unique approach, developed by the founders at UC Berkeley, uses an engineered template-independent polymerase conjugated to a single nucleoside triphosphate molecule to rapidly build a DNA sequence one base at a time.

Last updated on

About Ansa Biotechnologies

Founded

2018

Estimated Revenue

$1M-$10M

Employees

51-250

Funding / Mkt. Cap

$83M

Category

Industry

Social Services

Location

City

Emeryville

State

California

Country

United States
Ansa Biotechnologies

Ansa Biotechnologies

Find your buyer within Ansa Biotechnologies

Tech Stack (45)

search